Viral mixed infection complicated by acute hepatitis and allergic toxic dermatitis (clinical case)

Epstein-Barr virus (EBV) belongs to the family of herpesviruses (herpes type 4) and is one most common highly contagious. During pandemic a new coronavirus disease, it was found that in patients previously infected with EBV, COVID-19 can cause its reactivation, which often manifested by clinic acute hepatitis. The article presents clinical case development hepatitis patient mixed infection EBV SARS-CoV-2 combination allergic toxic reaction while taking sulfasalazine prescribed for spondyloarthritis. A feature this severe genesis favorable outcome. importance adherence drug monitoring rules newly drugs emphasized. In cases possibility should be taken into account.